Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

452
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
452
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

506
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
506
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

856
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
856
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

788
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
788
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

513
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
513

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.

Open forum infectious diseases·2026
Same author

Identifying Gaps in Tuberculosis Preventive Care for Non-U.S.-born Persons at Community Health Clinics in the United States.

Open forum infectious diseases·2025
Same author

Identifying gaps in tuberculosis preventive care for non-U.S.-born persons at community health clinics in the United States.

medRxiv : the preprint server for health sciences·2025
Same author

Executive Summary: State-of-the-Art Review: Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Expanding evidence for shortened treatment of latent tuberculosis infection: progress, not perfection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024

Related Experiment Video

Updated: Jan 3, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.1K

Diagnostic Tests for Latent Tuberculosis Infection.

Michelle K Haas1, Robert W Belknap1

  • 1Denver Metro Tuberculosis Program, Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA; Division of Infectious Diseases, Department of Medicine, University of Colorado-Denver Anschutz Medical Campus, 13001 E 17th Pl, Aurora, CO 80045, USA.

Clinics in Chest Medicine
|November 17, 2019
PubMed
Summary

Diagnosing latent tuberculosis infection (LTBI) is crucial for TB prevention. Current tests like TST and IGRAs have limitations, highlighting the need for improved diagnostic methods to predict TB risk.

Keywords:
Interferon-gamma release assayLTBILatent tuberculosis infectionQuantiFERONT-SPOT.TBTSTTuberculin skin test

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K

Related Experiment Videos

Last Updated: Jan 3, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.1K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Latent tuberculosis infection (LTBI) diagnosis is vital for global tuberculosis (TB) prevention strategies.
  • Current diagnostic methods include the tuberculin skin test (TST) and interferon-gamma release assays (IGRAs).
  • IGRAs are favored in populations vaccinated with bacille Calmette-Guérin, while TST remains an option due to cost and logistical factors.

Purpose of the Study:

  • To review the current landscape of LTBI diagnostic tests.
  • To identify the limitations of existing immunologic tests for LTBI.
  • To underscore the need for novel diagnostic tools that better predict future TB risk.

Main Methods:

  • Review of current diagnostic modalities for LTBI.
  • Comparative analysis of TST and IGRA performance characteristics.
  • Discussion of the predictive value of existing tests.

Main Results:

  • Both TST and IGRAs measure immunologic responses to TB infection.
  • IGRAs offer advantages over TST in specific populations (e.g., BCG-vaccinated).
  • A significant limitation of both TST and IGRAs is their low positive predictive value.

Conclusions:

  • Existing tests for LTBI have limitations in predicting future TB disease.
  • There is a critical need for advanced diagnostic tests that can differentiate the TB spectrum.
  • Improved tests are required to accurately assess future TB risk and guide preventive interventions.